Jul 24 2014
Research and Markets has announced the addition of the "Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
The global biomaterials market was valued at USD 25,277.8 million in 2012 and is expected to reach USD 33,600 million in 2019, growing at a CAGR of 4.1% during the forecast period 2013 to 2019
The biomaterials market has been extensively analyzed on the basis of material types, their use in various healthcare applications, success rate and geographical reach. Material type segment includes metals, polymers, ceramics and biomaterials derived from natural origin. Each material type is further segmented into various healthcare applications namely, cardiology, orthopedics, dental, ophthalmology and others which include urology, neurology and gasteroenterology. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia and Rest of the World (RoW).
Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.
A competitive landscape, mapping all the market players is provided in this report. The players profiled in this report include AdvanSource Biomaterials Corporation, Biomet, Inc., Celanese Corporation, Ceradyne, Inc., Collagen Matrix, Inc., DuPont, Evonik Industries AG, Corbion Purac, Ulbrich Stainless Steel & Special Metals, Inc., Royal DSM and Invibio, Inc. Each of these market players are profiled in this report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.